Navigation Links
STAAR Surgical Announces Second Quarter 2013 Results Release Date And Conference Call And Webcast
Date:7/18/2013

MONROVIA, Calif., July 18, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) today announced that it will release its financial results for the second quarter ended June 28, 2013 on Wednesday, July 31, 2013 after the market close.  The Company will host a conference call and webcast on Wednesday, July 31, 2013 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the Company's second quarter results and recent corporate developments. The dial-in number for the conference call is 877-703-6105 for domestic participants and 857-244-7304 for international participants, both using the passcode 23510067.

The Company will also be using slides to illustrate its second quarter results and operational progress.  The slides and live webcast of the call can be accessed from the investor relations section of the STAAR website at www.staar.com.A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days.  This replay can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers, both using passcode 40120994  An archived webcast will also be available at www.staar.com.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 350,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.  CONTACT: 

InvestorsMediaEVC Group

EVC GroupLeigh Salvo

Chris GaleDoug Sherk

646-201-5431415-568-9348
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical To Present At Upcoming Investor Conferences
2. STAAR Surgical Reports Strong First Quarter 2013 Financial Results
3. STAAR Surgical Provides Preliminary First Quarter Revenue Results
4. STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
5. STAAR Surgical Reports Third Quarter 2012 Financial Results
6. STAAR Surgical Appoints Charles Slacik To Its Board Of Directors
7. STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
8. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
9. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
10. STAAR Surgical Reports Second Quarter 2012 Financial Results
11. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 ... ... US$ 7,167.6 Mn in 2015, and is expected to reach ... 5.6% from 2016 to 2024. The global ...
(Date:4/19/2017)... 2017 Cardiology devices segment is anticipated to reach ... The Cardiology Devices segment is likely to create absolute $ ... 2018 over 2017. By the end of 2027, Cardiology Devices ... US$ 700 Mn, expanding at a CAGR of 18.4% over ... Asia Pacific reprocessed medical devices market in ...
(Date:4/19/2017)... Tenn. and DALLAS , April 19, 2017 ... announced that the first patients in Nashville ... device in the Lower Esophageal Sphincter Stimulation for GERD ... implantable device designed to provide long-term reflux control by ... GERD affects nearly 65 million people in ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/27/2017)... ... April 27, 2017 , ... Today, Jefferson Health in ... Colorado, announced an agreement to create the Jane and Leonard Korman Respiratory Institute ... and Leonard Korman Family Foundation. The collaboration leverages the strengths of each organization ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders ... of Thinksport’s award-winning sunscreen they’ve used the same scientific approach to solving smelly, ... deodorants flood the aisles that contain harmful chemicals that should be put nowhere ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, Inc. , the ... MobileIron Live! 2017 in Santa Clara, California. Each year, MobileIron Live! assembles ... helping organizations maximize the benefits of mobility in their operations securely. MobileIron ...
(Date:4/27/2017)... ... April 27, 2017 , ... Are you investing in ... in water-related accidents and drownings during the summer. While most of us assume this ... situations occur every day. Very few people are taking the time to learn how ...
Breaking Medicine News(10 mins):